JUN 10, 2015 09:00 AM PDT

Shiga toxin-producing E. coli (STEC): What you Need to Know Now

  • Director of Scientific Affairs, Alere
      Dr. Moore received his Bachelor's Degree in biology and philosophy from Dartmouth College and his PhD in microbiology from the University of New Hampshire. He developed the first ever rapid tests for Legionella and S. pneumoniae, both of which are now recommended by the Infectious Disease Society of America for use in severe pneumonia cases among other tests. He has multiple patents, publications, and presentations and now serves as the director of scientific affairs for infectious diseases. He has served on multiple NIAID grant committees, the College of American Pathology Point-of-Care Committee, and the Clinical Laboratory Standards Institute guideline committee for point-of-care infectious disease.

    When a patient presents with acute bloody diarrhea and tests negative for common causes such as campylobacter and salmonella, what's missing? Shiga toxin-producing E. coli (STEC) is increasing in prevalence and responsible for a growing number of outbreaks. Per CDC guidelines, rapid accurate diagnosis is critical to reduce the risk of developing life-threatening complications. We will explore newly published studies that emphasize the variability in sensitivity of available testing methods, and examine the impacts to workflow and clinical utility of broth-based testing and direct stool assays. How the CDC recommendations affect assay choices and impact epidemiology will also be discussed. Learning Objectives: Understand the background, prevalence, and clinical significance of Shiga toxin-producing E. coli (STEC) Examine the current diagnostic options available for Shiga toxin-producing E. coli (STEC) Discuss the current guidelines and recommendations regarding Shiga toxin-producing E. coli (STEC)

    Show Resources
    Loading Comments...